Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry for patients with congenital heart disease

Official title: Invasive Hemodynamic Control Cohort for The Mayo Clinic Adult Congenital Heart Disease (MACHD) Registry

Run by Mayo Clinic · NCT05849025 · Data updated 2026-11-12

This study is gathering information from adults with congenital heart disease to better understand their health and improve care for them.

More Congenital Heart Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedOctober 16, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 5, 2026
Trial IDNCT05849025 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with congenital heart disease who meet specific health criteria and can undergo an MRI.

Probably not a fit

Patients with a history of cardiovascular disease or those currently taking cardiac medication may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather comparative data for the Mayo Clinic Adult Congenital Heart Disease Registry. It will involve patients who meet specific health criteria, including those with a BMI of 30 or less and stable blood pressure levels. Participants will undergo assessments to ensure they can consent and meet kidney function requirements. The study will help enhance understanding of congenital heart disease in adults.

Why it matters

Potential benefit: If successful, this study could improve the management and treatment strategies for adults with congenital heart disease.

How similar studies have gone: Other studies have shown success in utilizing registries for congenital heart disease, indicating this approach is supported by prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Capacity to Consent
* BMI \</= 30
* Systolic BP \</= 140mmHg
* Diastolic BP \</= 90
* eGFR \> 30 (within prior 3 months) to confirm kidney function
* Able to undergo an MRI

Exclusion Criteria:

* History of Cardiovascular disease that may affect the results of the testing performed.
* Any Current orthopedic limitations
* Currently taking any cardiac medication
* Pregnancy

Where it's running

  • Mayo Clinic Rochester
    Rochester, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Alexander Egbe, MBBS, MPH — Mayo Clinic
  • Study coordinator: ACHD Research Program
  • Phone: (507) 293-2565

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.